You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

Open menu

News

Scarlet Therapeutics gains funding for blood cell platform

Scarlet Therapeutics – a company focused on developing red blood cell therapeutics – has announced that it has generated seed funding from both Meltwind and Science Creates Ventures.